Home » Topics » Regulatory

Regulatory
RSS

Seretide MDI approved in the U.K. for asthma Rx

June 19, 2000

Nastech reports pilot phase I trial results for new formulation of butorphanol

June 19, 2000

Topiramate reportedly useful in posttraumatic stress disorder

June 16, 2000

Xeloda approved in New Zealand as treatment for colorectal cancer

June 16, 2000

FDA approval of Targis System Express Protocol shortens treatment time

June 15, 2000

Combination therapy for HCV, particularly following liver transplant, patented

June 14, 2000

Venlafaxine effective in the treatment of painful diabetic neuropathy

June 14, 2000

Metamizole: controlled-release tablets described by Italian laboratory

June 14, 2000

More effective, better tolerated combinations for migraine

June 9, 2000

Rizatriptan + rofecoxib claimed by Merck for use in migraine

June 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...